Back to Results
First PageMeta Content
Council of Europe / Validity / Pharmaceuticals policy / Health / Medicine / European Directorate for the Quality of Medicines / Validation / Regulatory requirement / Good manufacturing practice / Pharmaceutical industry / Pharmaceutical sciences / Food safety


        Position Paper
Add to Reading List

Document Date: 2014-08-05 08:39:34

Open Document

File Size: 198,26 KB

Share Result on Facebook

City

Geneva / Bruxelles / /

Company

AAPS Pharm / J. Levons A. S. / J. Pharm / /

Country

Guinea / United States / China / /

Facility

P. Castle / Paul Ehrlich Institute / /

IndustryTerm

validated manufacturing process / biological products / serum products / pharmaceuticals / therapeutic synthetic peptide products / pharmaceutical industry / blood products / manufacturing practices / biological product / biotechnological products / manufacturing / pharmaceutical manufacturers / license applications / drug products / e.g. mass spectrometry applications / plasmid products / monoclonal antibody products / manufacturing process / marketed products / /

MedicalCondition

sterility / diphtheria / tetanus / illness / /

MedicalTreatment

antibiotics / /

Organization

EFPIA / World Health Organization / FDA / WHO Expert Committee on Biological Harmonisation / European Union / European Parliament / Expert Committee on Biological Standardization / Paul Ehrlich Institute / /

Person

Gustav Fischer / M. Van De Weert / /

/

Position

Editor / General / /

ProvinceOrState

Quebec / /

Technology

biopharmaceuticals / Antibodies / process control / recombinant DNA / Recombinant DNA Technology / /

URL

www.efpia.eu / /

SocialTag